Charles River Laboratories International, Inc.CRLNYSE
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank87
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P87
Within normal range
vs 2Y Ago
3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.50% |
| Q3 2025 | -5.55% |
| Q2 2025 | -6.69% |
| Q1 2025 | 9.61% |
| Q4 2024 | -1.29% |
| Q3 2024 | -2.77% |
| Q2 2024 | -7.81% |
| Q1 2024 | 0.40% |
| Q4 2023 | 5.57% |
| Q3 2023 | -5.70% |
| Q3 2023 | -2.59% |
| Q2 2023 | 2.09% |
| Q4 2022 | -7.62% |
| Q3 2022 | -1.81% |
| Q2 2022 | 14.54% |
| Q1 2022 | -7.01% |
| Q4 2021 | 1.10% |
| Q3 2021 | 5.64% |
| Q2 2021 | 24.85% |
| Q1 2021 | 11.30% |
| Q4 2020 | -1.26% |
| Q3 2020 | -10.08% |
| Q2 2020 | -3.86% |
| Q1 2020 | 24.97% |
| Q4 2019 | -1.38% |
| Q3 2019 | -6.76% |
| Q2 2019 | 29.57% |
| Q1 2019 | 0.13% |
| Q4 2018 | 0.76% |
| Q3 2018 | -7.85% |
| Q2 2018 | 61.36% |
| Q1 2018 | -1.08% |
| Q4 2017 | -3.21% |
| Q3 2017 | 3.46% |
| Q3 2017 | -4.50% |
| Q2 2017 | -3.05% |
| Q4 2016 | -1.92% |
| Q3 2016 | -7.75% |
| Q2 2016 | 58.38% |
| Q1 2016 | -0.14% |